1
Lisa A. de Jong, Judith J. Gout-Zwart, Jelena Stevanovic, Harrie Rila, Mike Koops, Menno V. Huisman, Maarten J. Postma
Veröffentlicht in: TH Open, Vol 02, Iss 03, Pp e315-e324 (2018);
2018
Veröffentlicht in: TH Open, Vol 02, Iss 03, Pp e315-e324 (2018);
2018
2
Heisen, Marieke, Treur, Maarten J, Heemstra, Harald E, Giesen, Eric B W, Postma, Maarten J
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
Veröffentlicht in: Heisen , M , Treur , M J , Heemstra , H E , Giesen , E B W & Postma , M J 2017 , ' Cost-effectiveness analysis of rivaroxaban for treatment and secondary prevention of venous thromboembolism in the Netherlands ' , Journal of Medical Economics , vol. 20 , no. 8 , 0046-RT.R1/1331912 , pp. 813-824 . https://doi.org/10.1080/13696998.2017.1331912;
2017
3
De Jong, Lisa A., Gout-Zwart, Judith J., Stevanovic, Jelena, Rila, Harrie, Koops, Mike, Huisman, Menno V., Postma, Maarten J.
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018
Veröffentlicht in: De Jong , L A , Gout-Zwart , J J , Stevanovic , J , Rila , H , Koops , M , Huisman , M V & Postma , M J 2018 , ' Extended Treatment with Apixaban for Venous Thromboembolism Prevention in the Netherlands : Clinical and Economic Effects ' , BMJ Open , vol. 2 , no. 3 , pp. e315-e324 . https://doi.org/10.1055/s-0038-1672185;
2018